PubMed Health⌕ Search

Biomedical subjects

N Ackerman

Publications and source records attributed to N Ackerman.

At least 19 recordsLinked to original sources
PubMed1992

Surgical treatment of dorsal cortical fractures of the third metacarpal bone in thoroughbred racehorses: 53 cases (1985-1989).

Between January 1985 and May 1989, 53 Thoroughbred horses (mean age 3.2 years) were surgically treated for dorsal cortical fractures of the third metacarpal bone (MC III). All horses were treated with cortical drilling through the fracture line (osteostixis). Diagnosis of the fractures was confirmed by xeroradiography. Lifetime racing records were obtained for all horses. Forty-seven horses returned to racing after surgery (89%). The mean time between surgery and the first race was 6.8 months. Horses had a mean of 10.9 starts before surgery and 16.1 starts after surgery. The mean earnings per start before surgery was $6,459 and after surgery was $5,685. Of the 47 horses that raced after surgery, 70% raced at the same class or improved. Complications related to surgery were seen in 10 horses. Two horses had a second fracture of MC III at the same site, and were again treated by osteostixis, after which both horses returned to competition. Fractured drill bits were left in the MC III of 4 horses. One of these horses had catastrophic failure of MC III. Two horses developed subcutaneous infections and 2 horses had catastrophic failure of MC III in the surgically treated limb. Osteostixis appears to be an effective treatment for returning horses affected with dorsal cortical fractures to racing.

Animals↗
PubMed1992

Evaluation and comparison of automated biopsy devices. Work in progress.

The performance of four automated biopsy devices (Bard Biopty, Bard Monopty, Microvasive ASAP 18, Medical Device Technologies Ultra-Cut) was compared when they were used to obtain 96 liver and 96 kidney samples from eight dogs under ultrasound guidance. There was no significant difference in the lengths of the samples obtained with the four devices. The Monopty device yielded a significantly greater mean weight of both kidney (30.8%) and liver (31.6%) samples compared with the other devices. There were no significant differences between the four devices relative to cellular and histologic preservation, crush artifact, and number of renal glomeruli or liver lobules and portal triads. Renal subcapsular hematomas were identified in most instances, and there was no difference between the devices in the amount of renal trauma resulting from their use. There was only one instance of severe injury to the liver. The choice of instrument should remain one of personal preference, since all four devices were satisfactory and none produced significantly greater renal or hepatic injury.

Animals↗
PubMed1992

192iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs.

After surgical removal of a primary intranasal neoplasm, an implant device, designed to deliver 192iridium (192Ir) brachytherapy, was positioned in the nasal cavity of 8 dogs. Ribbons containing 192Ir seeds were placed in the device, using an afterloading technique. Dosimetry, to a dose of 7,000 to 10,000 centiGray (cGy), was calculated to encompass the site previously occupied by the tumor and a 1-cm margin of surrounding normal tissue. The quantity of 192Ir implanted varied between 16.69 and 100.80 mg of radium equivalent. The duration of implantation ranged from 90 to 168 hours. All dogs tolerated the implant well, but had a mucoid nasal discharge after radiotherapy. The implant device allowed rapid application and removal of the radioactive ribbons. Mean (+/- SD) radiation exposure to each radiotherapist during seed loading and unloading was 14.4 (+/- 5.3) and 4.5 (+/- 0.9) mrem, respectively. A uniform dose distribution around the intranasal implant device was achieved; however, dogs that received doses in excess of 9,400 cGy at the dorsolateral surface of the nose and/or hard palate had bone and soft tissue necrosis between 70 and 120 days after treatment. One dog was euthanatized 50 days after treatment because of metastatic disease, and 2 dogs were euthanatized because of local tumor recurrence at 125 and 212 days. Death, considered unrelated to treatment, occurred in 1 dog that was euthanatized 27 days after treatment and in 3 dogs that died 30, 93, and 456 days after treatment. Necropsy was performed on 3 of these dogs and evidence of intranasal neoplasia was not observed. One dog remained disease-free at 587 days after treatment.

Adenocarcinoma↗
PubMed1991

Unilateral congenital aneurysm of the jugular, linguofacial, and maxillary veins in a dog.

A 5-month-old female Gordon Setter was examined because of a soft, fluctuant, subcutaneous swelling in the right submandibular region. Clinical problems were not associated with the mass. Cytologic examination and blood gas analysis of an aspirate from the mass confirmed its contents to be venous blood. Venous angiography delineated a fusiform dilatation of the right jugular, maxillary, and linguofacial veins, with no evidence of obstruction or anomalous venous return to the heart. The dilated segments were surgically excised, and the tissue was submitted for histologic examination. The clinical, radiographic, and histologic features of this lesion supported the diagnosis of congenital venous aneurysm.

Aneurysm↗
PubMed1990

In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1 beta. II. Mechanism of inhibition: the role of polymorphonuclear leukocytes.

Recombinant human interleukin 1 beta (IL 1 beta) inhibits growth of B16 melanoma in syngeneic C57BL/6 mice in a dose-dependent manner when given intratumorally, intradermally, or intramuscularly over a period of 5 to 7 days. Inhibition of tumor growth was rapid and measurable within 3 days after the initial injection and occurred regardless of the route of injection. However, only intratumoral (ITU) injections of IL 1 beta resulted in greater than 90% inhibition in tumor growth. This enhanced inhibition of tumor growth was not dependent on T or NK cells since inhibition of tumor growth occurred in nude and Beige mice. Also, a profound lymphopenia occurred in mice receiving IL 1 beta. Inhibition of tumor growth did correlate with an increase in the number of polymorphonuclear leukocytes (PMN's) in the circulation. However, only ITU injections of IL 1 beta increased the number of PMN's within the tumors. IM injections of IL 1 beta, while increasing the number of PMN's in the circulation, did not increase the influx of PMN's into the tumors. Furthermore, the transfer of PMN's directly into B16 tumors caused a 49% reduction in tumor growth without the presence of IL 1 beta. These results suggest that in vivo, PMN's may effectively control the growth of tumors and that IL 1 beta may increase this effectiveness by increasing the number of PMN's in the circulation and by locally stimulating the production of chemotactic factors for PMN's within the tumor.

Animals↗
PubMed1979

Lymphosarcoma and cryptococcosis in a cat.

Cryptococcosis and lymphosarcoma were diagnosed in a 3-year-old Domestic Shorthair cat. The cat was studied immunologically, and abnormal findings included absolute lymphopenia, with a low percentage of the lymphocytes having cell surface markers of normal T and B cells, decreased responsiveness to mitogens, and low immunoglobulin concentrations in serum. Necropsy revealed cryptococcal lesions in the facial area. The cortex of the left kidney was replaced by a diffuse pattern of undifferentiated large cells compatible with those of histiocytic cell type lymphosarcoma.

Animals↗
PubMed1979

Release of cartilage proteoglycan degrading enzyme activity by thioglycollate stimulated mouse peritoneal macrophages in culture.

Media from cultured mouse peritoneal macrophages were tested for cartilage proteoglycan degrading activity using S35-labelled rabbit ear cartilage. Media samples collected at 2-day intervals contained increasing amounts of activity between days two and six. This activity was activated by trypsin and antagonized by chelating agents. The macrophage products induced release of the proteoglycan component of cartilage as determined by biochemical and histological methods without affecting the collagen component. Media from cells incubated with hydrocortisone were devoid of proteoglycan degrading activity.

Animals↗
PubMed1979

Intraconal contrast orbitography in the dog.

Intraconal contrast orbitograms were obtained, using a nonionic water-soluble contrast agent, on 15 normal dogs to evaluate the technique and to define the basal orbitogram. Thirty-three intraconal orbitograms were prepared, utilizing three different injection techniques. In 21 of the intraconal orbitograms, the orbital cone was well outlined with contrast or with the optic nerve visible (or both). These were judged to be of satisfactory diagnostic quality. In the 12 other studies, the presence of most of the contrast material outside the orbital cone resulted in failure to identify the intraconal structures. These were, therefore, classified as nondiagnostic. The contrast agent used provided an adequate density and persisted in the orbital cone long enough for radiograms to be obtained. Serious complications did not appear during the study. Intraconal orbitography provides a safe method for evaluating the orbital cone.

Animals↗
PubMed1979

Percutaneous nephropyelocentesis and nephropyelostomy in the dog: a description of the technique.

Percutaneous nephropyelocentesis or nephropyelostomy was done on 20 anesthetized dogs of both sexes with the aid of fluoroscopy. The upper urinary tracts were visualized by the use of IV radiopaque contrast material and distended by application of an abdominal compression band positioned over the caudal abdomen. Renal pelvic urine was readily obtained by both procedures in each dog. Bloody urine was an infrequent result, and usually occured only after repeated attempts had been made to enter the renal pelvic lumen. To ascertain the degree of renal parenchymal damage caused by passage of the needle and catheter, dogs were euthanatized and necropsied on the 1st, 3rd, 7th, and 14th days after the procedure was done. Repair of the tissue damage was rapid and the lesions were difficult to visualize grossly by the 14th day.

Animals↗
PubMed1978

Splenic disease.

Explore the source record for details and available documents.

Animals↗